Global Vonoprazan Fumarate API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Vonoprazan Fumarate(CAS?1260141-27-2) is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB), with potential antacid activity.
LPI (LP Information)' newest research report, the “Vonoprazan Fumarate API Industry Forecast” looks at past sales and reviews total world Vonoprazan Fumarate API sales in 2022, providing a comprehensive analysis by region and market sector of projected Vonoprazan Fumarate API sales for 2023 through 2029. With Vonoprazan Fumarate API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vonoprazan Fumarate API industry.
This Insight Report provides a comprehensive analysis of the global Vonoprazan Fumarate API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vonoprazan Fumarate API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vonoprazan Fumarate API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vonoprazan Fumarate API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vonoprazan Fumarate API.
The global Vonoprazan Fumarate API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vonoprazan Fumarate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vonoprazan Fumarate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vonoprazan Fumarate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vonoprazan Fumarate API players cover Ami Lifesciences Private Limited, Dr. Reddy's Laboratories, Hetero Drugs, Metrochem API Private Limited, Nippon Zhenlei Chemical, Virupaksha Organics, Zhejiang Hengkang Pharmaceutical, Maithri Drugs and Xian Wanlong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vonoprazan Fumarate API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Vonoprazan Fumarate API market?
What factors are driving Vonoprazan Fumarate API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vonoprazan Fumarate API market opportunities vary by end market size?
How does Vonoprazan Fumarate API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Vonoprazan Fumarate(CAS?1260141-27-2) is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB), with potential antacid activity.
LPI (LP Information)' newest research report, the “Vonoprazan Fumarate API Industry Forecast” looks at past sales and reviews total world Vonoprazan Fumarate API sales in 2022, providing a comprehensive analysis by region and market sector of projected Vonoprazan Fumarate API sales for 2023 through 2029. With Vonoprazan Fumarate API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vonoprazan Fumarate API industry.
This Insight Report provides a comprehensive analysis of the global Vonoprazan Fumarate API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vonoprazan Fumarate API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vonoprazan Fumarate API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vonoprazan Fumarate API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vonoprazan Fumarate API.
The global Vonoprazan Fumarate API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vonoprazan Fumarate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vonoprazan Fumarate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vonoprazan Fumarate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vonoprazan Fumarate API players cover Ami Lifesciences Private Limited, Dr. Reddy's Laboratories, Hetero Drugs, Metrochem API Private Limited, Nippon Zhenlei Chemical, Virupaksha Organics, Zhejiang Hengkang Pharmaceutical, Maithri Drugs and Xian Wanlong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vonoprazan Fumarate API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Above 98 %
- Above 99 %
- Tablets
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ami Lifesciences Private Limited
- Dr. Reddy's Laboratories
- Hetero Drugs
- Metrochem API Private Limited
- Nippon Zhenlei Chemical
- Virupaksha Organics
- Zhejiang Hengkang Pharmaceutical
- Maithri Drugs
- Xian Wanlong Pharmaceutical
- Morepen Laboratories
What is the 10-year outlook for the global Vonoprazan Fumarate API market?
What factors are driving Vonoprazan Fumarate API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vonoprazan Fumarate API market opportunities vary by end market size?
How does Vonoprazan Fumarate API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vonoprazan Fumarate API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vonoprazan Fumarate API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vonoprazan Fumarate API by Country/Region, 2018, 2022 & 2029
2.2 Vonoprazan Fumarate API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Vonoprazan Fumarate API Sales by Type
2.3.1 Global Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
2.3.2 Global Vonoprazan Fumarate API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vonoprazan Fumarate API Sale Price by Type (2018-2023)
2.4 Vonoprazan Fumarate API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Vonoprazan Fumarate API Sales by Application
2.5.1 Global Vonoprazan Fumarate API Sale Market Share by Application (2018-2023)
2.5.2 Global Vonoprazan Fumarate API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vonoprazan Fumarate API Sale Price by Application (2018-2023)
3 GLOBAL VONOPRAZAN FUMARATE API BY COMPANY
3.1 Global Vonoprazan Fumarate API Breakdown Data by Company
3.1.1 Global Vonoprazan Fumarate API Annual Sales by Company (2018-2023)
3.1.2 Global Vonoprazan Fumarate API Sales Market Share by Company (2018-2023)
3.2 Global Vonoprazan Fumarate API Annual Revenue by Company (2018-2023)
3.2.1 Global Vonoprazan Fumarate API Revenue by Company (2018-2023)
3.2.2 Global Vonoprazan Fumarate API Revenue Market Share by Company (2018-2023)
3.3 Global Vonoprazan Fumarate API Sale Price by Company
3.4 Key Manufacturers Vonoprazan Fumarate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vonoprazan Fumarate API Product Location Distribution
3.4.2 Players Vonoprazan Fumarate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VONOPRAZAN FUMARATE API BY GEOGRAPHIC REGION
4.1 World Historic Vonoprazan Fumarate API Market Size by Geographic Region (2018-2023)
4.1.1 Global Vonoprazan Fumarate API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vonoprazan Fumarate API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vonoprazan Fumarate API Market Size by Country/Region (2018-2023)
4.2.1 Global Vonoprazan Fumarate API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vonoprazan Fumarate API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vonoprazan Fumarate API Sales Growth
4.4 APAC Vonoprazan Fumarate API Sales Growth
4.5 Europe Vonoprazan Fumarate API Sales Growth
4.6 Middle East & Africa Vonoprazan Fumarate API Sales Growth
5 AMERICAS
5.1 Americas Vonoprazan Fumarate API Sales by Country
5.1.1 Americas Vonoprazan Fumarate API Sales by Country (2018-2023)
5.1.2 Americas Vonoprazan Fumarate API Revenue by Country (2018-2023)
5.2 Americas Vonoprazan Fumarate API Sales by Type
5.3 Americas Vonoprazan Fumarate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vonoprazan Fumarate API Sales by Region
6.1.1 APAC Vonoprazan Fumarate API Sales by Region (2018-2023)
6.1.2 APAC Vonoprazan Fumarate API Revenue by Region (2018-2023)
6.2 APAC Vonoprazan Fumarate API Sales by Type
6.3 APAC Vonoprazan Fumarate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vonoprazan Fumarate API by Country
7.1.1 Europe Vonoprazan Fumarate API Sales by Country (2018-2023)
7.1.2 Europe Vonoprazan Fumarate API Revenue by Country (2018-2023)
7.2 Europe Vonoprazan Fumarate API Sales by Type
7.3 Europe Vonoprazan Fumarate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vonoprazan Fumarate API by Country
8.1.1 Middle East & Africa Vonoprazan Fumarate API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vonoprazan Fumarate API Revenue by Country (2018-2023)
8.2 Middle East & Africa Vonoprazan Fumarate API Sales by Type
8.3 Middle East & Africa Vonoprazan Fumarate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vonoprazan Fumarate API
10.3 Manufacturing Process Analysis of Vonoprazan Fumarate API
10.4 Industry Chain Structure of Vonoprazan Fumarate API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vonoprazan Fumarate API Distributors
11.3 Vonoprazan Fumarate API Customer
12 WORLD FORECAST REVIEW FOR VONOPRAZAN FUMARATE API BY GEOGRAPHIC REGION
12.1 Global Vonoprazan Fumarate API Market Size Forecast by Region
12.1.1 Global Vonoprazan Fumarate API Forecast by Region (2024-2029)
12.1.2 Global Vonoprazan Fumarate API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vonoprazan Fumarate API Forecast by Type
12.7 Global Vonoprazan Fumarate API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ami Lifesciences Private Limited
13.1.1 Ami Lifesciences Private Limited Company Information
13.1.2 Ami Lifesciences Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
13.1.3 Ami Lifesciences Private Limited Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ami Lifesciences Private Limited Main Business Overview
13.1.5 Ami Lifesciences Private Limited Latest Developments
13.2 Dr. Reddy's Laboratories
13.2.1 Dr. Reddy's Laboratories Company Information
13.2.2 Dr. Reddy's Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
13.2.3 Dr. Reddy's Laboratories Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dr. Reddy's Laboratories Main Business Overview
13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 Hetero Drugs
13.3.1 Hetero Drugs Company Information
13.3.2 Hetero Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
13.3.3 Hetero Drugs Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hetero Drugs Main Business Overview
13.3.5 Hetero Drugs Latest Developments
13.4 Metrochem API Private Limited
13.4.1 Metrochem API Private Limited Company Information
13.4.2 Metrochem API Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
13.4.3 Metrochem API Private Limited Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Metrochem API Private Limited Main Business Overview
13.4.5 Metrochem API Private Limited Latest Developments
13.5 Nippon Zhenlei Chemical
13.5.1 Nippon Zhenlei Chemical Company Information
13.5.2 Nippon Zhenlei Chemical Vonoprazan Fumarate API Product Portfolios and Specifications
13.5.3 Nippon Zhenlei Chemical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nippon Zhenlei Chemical Main Business Overview
13.5.5 Nippon Zhenlei Chemical Latest Developments
13.6 Virupaksha Organics
13.6.1 Virupaksha Organics Company Information
13.6.2 Virupaksha Organics Vonoprazan Fumarate API Product Portfolios and Specifications
13.6.3 Virupaksha Organics Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Virupaksha Organics Main Business Overview
13.6.5 Virupaksha Organics Latest Developments
13.7 Zhejiang Hengkang Pharmaceutical
13.7.1 Zhejiang Hengkang Pharmaceutical Company Information
13.7.2 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
13.7.3 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
13.7.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.8 Maithri Drugs
13.8.1 Maithri Drugs Company Information
13.8.2 Maithri Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
13.8.3 Maithri Drugs Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Maithri Drugs Main Business Overview
13.8.5 Maithri Drugs Latest Developments
13.9 Xian Wanlong Pharmaceutical
13.9.1 Xian Wanlong Pharmaceutical Company Information
13.9.2 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
13.9.3 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Xian Wanlong Pharmaceutical Main Business Overview
13.9.5 Xian Wanlong Pharmaceutical Latest Developments
13.10 Morepen Laboratories
13.10.1 Morepen Laboratories Company Information
13.10.2 Morepen Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
13.10.3 Morepen Laboratories Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Morepen Laboratories Main Business Overview
13.10.5 Morepen Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vonoprazan Fumarate API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vonoprazan Fumarate API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vonoprazan Fumarate API by Country/Region, 2018, 2022 & 2029
2.2 Vonoprazan Fumarate API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Vonoprazan Fumarate API Sales by Type
2.3.1 Global Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
2.3.2 Global Vonoprazan Fumarate API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vonoprazan Fumarate API Sale Price by Type (2018-2023)
2.4 Vonoprazan Fumarate API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Vonoprazan Fumarate API Sales by Application
2.5.1 Global Vonoprazan Fumarate API Sale Market Share by Application (2018-2023)
2.5.2 Global Vonoprazan Fumarate API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vonoprazan Fumarate API Sale Price by Application (2018-2023)
3 GLOBAL VONOPRAZAN FUMARATE API BY COMPANY
3.1 Global Vonoprazan Fumarate API Breakdown Data by Company
3.1.1 Global Vonoprazan Fumarate API Annual Sales by Company (2018-2023)
3.1.2 Global Vonoprazan Fumarate API Sales Market Share by Company (2018-2023)
3.2 Global Vonoprazan Fumarate API Annual Revenue by Company (2018-2023)
3.2.1 Global Vonoprazan Fumarate API Revenue by Company (2018-2023)
3.2.2 Global Vonoprazan Fumarate API Revenue Market Share by Company (2018-2023)
3.3 Global Vonoprazan Fumarate API Sale Price by Company
3.4 Key Manufacturers Vonoprazan Fumarate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vonoprazan Fumarate API Product Location Distribution
3.4.2 Players Vonoprazan Fumarate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VONOPRAZAN FUMARATE API BY GEOGRAPHIC REGION
4.1 World Historic Vonoprazan Fumarate API Market Size by Geographic Region (2018-2023)
4.1.1 Global Vonoprazan Fumarate API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vonoprazan Fumarate API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vonoprazan Fumarate API Market Size by Country/Region (2018-2023)
4.2.1 Global Vonoprazan Fumarate API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vonoprazan Fumarate API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vonoprazan Fumarate API Sales Growth
4.4 APAC Vonoprazan Fumarate API Sales Growth
4.5 Europe Vonoprazan Fumarate API Sales Growth
4.6 Middle East & Africa Vonoprazan Fumarate API Sales Growth
5 AMERICAS
5.1 Americas Vonoprazan Fumarate API Sales by Country
5.1.1 Americas Vonoprazan Fumarate API Sales by Country (2018-2023)
5.1.2 Americas Vonoprazan Fumarate API Revenue by Country (2018-2023)
5.2 Americas Vonoprazan Fumarate API Sales by Type
5.3 Americas Vonoprazan Fumarate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vonoprazan Fumarate API Sales by Region
6.1.1 APAC Vonoprazan Fumarate API Sales by Region (2018-2023)
6.1.2 APAC Vonoprazan Fumarate API Revenue by Region (2018-2023)
6.2 APAC Vonoprazan Fumarate API Sales by Type
6.3 APAC Vonoprazan Fumarate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vonoprazan Fumarate API by Country
7.1.1 Europe Vonoprazan Fumarate API Sales by Country (2018-2023)
7.1.2 Europe Vonoprazan Fumarate API Revenue by Country (2018-2023)
7.2 Europe Vonoprazan Fumarate API Sales by Type
7.3 Europe Vonoprazan Fumarate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vonoprazan Fumarate API by Country
8.1.1 Middle East & Africa Vonoprazan Fumarate API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vonoprazan Fumarate API Revenue by Country (2018-2023)
8.2 Middle East & Africa Vonoprazan Fumarate API Sales by Type
8.3 Middle East & Africa Vonoprazan Fumarate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vonoprazan Fumarate API
10.3 Manufacturing Process Analysis of Vonoprazan Fumarate API
10.4 Industry Chain Structure of Vonoprazan Fumarate API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vonoprazan Fumarate API Distributors
11.3 Vonoprazan Fumarate API Customer
12 WORLD FORECAST REVIEW FOR VONOPRAZAN FUMARATE API BY GEOGRAPHIC REGION
12.1 Global Vonoprazan Fumarate API Market Size Forecast by Region
12.1.1 Global Vonoprazan Fumarate API Forecast by Region (2024-2029)
12.1.2 Global Vonoprazan Fumarate API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vonoprazan Fumarate API Forecast by Type
12.7 Global Vonoprazan Fumarate API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ami Lifesciences Private Limited
13.1.1 Ami Lifesciences Private Limited Company Information
13.1.2 Ami Lifesciences Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
13.1.3 Ami Lifesciences Private Limited Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ami Lifesciences Private Limited Main Business Overview
13.1.5 Ami Lifesciences Private Limited Latest Developments
13.2 Dr. Reddy's Laboratories
13.2.1 Dr. Reddy's Laboratories Company Information
13.2.2 Dr. Reddy's Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
13.2.3 Dr. Reddy's Laboratories Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dr. Reddy's Laboratories Main Business Overview
13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 Hetero Drugs
13.3.1 Hetero Drugs Company Information
13.3.2 Hetero Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
13.3.3 Hetero Drugs Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hetero Drugs Main Business Overview
13.3.5 Hetero Drugs Latest Developments
13.4 Metrochem API Private Limited
13.4.1 Metrochem API Private Limited Company Information
13.4.2 Metrochem API Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
13.4.3 Metrochem API Private Limited Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Metrochem API Private Limited Main Business Overview
13.4.5 Metrochem API Private Limited Latest Developments
13.5 Nippon Zhenlei Chemical
13.5.1 Nippon Zhenlei Chemical Company Information
13.5.2 Nippon Zhenlei Chemical Vonoprazan Fumarate API Product Portfolios and Specifications
13.5.3 Nippon Zhenlei Chemical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nippon Zhenlei Chemical Main Business Overview
13.5.5 Nippon Zhenlei Chemical Latest Developments
13.6 Virupaksha Organics
13.6.1 Virupaksha Organics Company Information
13.6.2 Virupaksha Organics Vonoprazan Fumarate API Product Portfolios and Specifications
13.6.3 Virupaksha Organics Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Virupaksha Organics Main Business Overview
13.6.5 Virupaksha Organics Latest Developments
13.7 Zhejiang Hengkang Pharmaceutical
13.7.1 Zhejiang Hengkang Pharmaceutical Company Information
13.7.2 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
13.7.3 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
13.7.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.8 Maithri Drugs
13.8.1 Maithri Drugs Company Information
13.8.2 Maithri Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
13.8.3 Maithri Drugs Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Maithri Drugs Main Business Overview
13.8.5 Maithri Drugs Latest Developments
13.9 Xian Wanlong Pharmaceutical
13.9.1 Xian Wanlong Pharmaceutical Company Information
13.9.2 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
13.9.3 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Xian Wanlong Pharmaceutical Main Business Overview
13.9.5 Xian Wanlong Pharmaceutical Latest Developments
13.10 Morepen Laboratories
13.10.1 Morepen Laboratories Company Information
13.10.2 Morepen Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
13.10.3 Morepen Laboratories Vonoprazan Fumarate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Morepen Laboratories Main Business Overview
13.10.5 Morepen Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vonoprazan Fumarate API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vonoprazan Fumarate API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 6. Global Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Table 7. Global Vonoprazan Fumarate API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vonoprazan Fumarate API Revenue Market Share by Type (2018-2023)
Table 9. Global Vonoprazan Fumarate API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 11. Global Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Table 12. Global Vonoprazan Fumarate API Revenue by Application (2018-2023)
Table 13. Global Vonoprazan Fumarate API Revenue Market Share by Application (2018-2023)
Table 14. Global Vonoprazan Fumarate API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Vonoprazan Fumarate API Sales by Company (2018-2023) & (Kg)
Table 16. Global Vonoprazan Fumarate API Sales Market Share by Company (2018-2023)
Table 17. Global Vonoprazan Fumarate API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vonoprazan Fumarate API Revenue Market Share by Company (2018-2023)
Table 19. Global Vonoprazan Fumarate API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Vonoprazan Fumarate API Producing Area Distribution and Sales Area
Table 21. Players Vonoprazan Fumarate API Products Offered
Table 22. Vonoprazan Fumarate API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vonoprazan Fumarate API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Vonoprazan Fumarate API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vonoprazan Fumarate API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vonoprazan Fumarate API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vonoprazan Fumarate API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Vonoprazan Fumarate API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vonoprazan Fumarate API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vonoprazan Fumarate API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vonoprazan Fumarate API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Vonoprazan Fumarate API Sales Market Share by Country (2018-2023)
Table 35. Americas Vonoprazan Fumarate API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vonoprazan Fumarate API Revenue Market Share by Country (2018-2023)
Table 37. Americas Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Vonoprazan Fumarate API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Vonoprazan Fumarate API Sales Market Share by Region (2018-2023)
Table 41. APAC Vonoprazan Fumarate API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vonoprazan Fumarate API Revenue Market Share by Region (2018-2023)
Table 43. APAC Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Vonoprazan Fumarate API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Vonoprazan Fumarate API Sales Market Share by Country (2018-2023)
Table 47. Europe Vonoprazan Fumarate API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vonoprazan Fumarate API Revenue Market Share by Country (2018-2023)
Table 49. Europe Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Vonoprazan Fumarate API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vonoprazan Fumarate API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vonoprazan Fumarate API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Vonoprazan Fumarate API
Table 58. Key Market Challenges & Risks of Vonoprazan Fumarate API
Table 59. Key Industry Trends of Vonoprazan Fumarate API
Table 60. Vonoprazan Fumarate API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vonoprazan Fumarate API Distributors List
Table 63. Vonoprazan Fumarate API Customer List
Table 64. Global Vonoprazan Fumarate API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Vonoprazan Fumarate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vonoprazan Fumarate API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Vonoprazan Fumarate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vonoprazan Fumarate API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Vonoprazan Fumarate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vonoprazan Fumarate API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Vonoprazan Fumarate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vonoprazan Fumarate API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Vonoprazan Fumarate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vonoprazan Fumarate API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Vonoprazan Fumarate API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vonoprazan Fumarate API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Vonoprazan Fumarate API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ami Lifesciences Private Limited Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 79. Ami Lifesciences Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
Table 80. Ami Lifesciences Private Limited Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Ami Lifesciences Private Limited Main Business
Table 82. Ami Lifesciences Private Limited Latest Developments
Table 83. Dr. Reddy's Laboratories Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 84. Dr. Reddy's Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
Table 85. Dr. Reddy's Laboratories Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Dr. Reddy's Laboratories Main Business
Table 87. Dr. Reddy's Laboratories Latest Developments
Table 88. Hetero Drugs Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 89. Hetero Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
Table 90. Hetero Drugs Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Hetero Drugs Main Business
Table 92. Hetero Drugs Latest Developments
Table 93. Metrochem API Private Limited Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 94. Metrochem API Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
Table 95. Metrochem API Private Limited Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Metrochem API Private Limited Main Business
Table 97. Metrochem API Private Limited Latest Developments
Table 98. Nippon Zhenlei Chemical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 99. Nippon Zhenlei Chemical Vonoprazan Fumarate API Product Portfolios and Specifications
Table 100. Nippon Zhenlei Chemical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Nippon Zhenlei Chemical Main Business
Table 102. Nippon Zhenlei Chemical Latest Developments
Table 103. Virupaksha Organics Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 104. Virupaksha Organics Vonoprazan Fumarate API Product Portfolios and Specifications
Table 105. Virupaksha Organics Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Virupaksha Organics Main Business
Table 107. Virupaksha Organics Latest Developments
Table 108. Zhejiang Hengkang Pharmaceutical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
Table 110. Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Zhejiang Hengkang Pharmaceutical Main Business
Table 112. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 113. Maithri Drugs Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 114. Maithri Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
Table 115. Maithri Drugs Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Maithri Drugs Main Business
Table 117. Maithri Drugs Latest Developments
Table 118. Xian Wanlong Pharmaceutical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 119. Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
Table 120. Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Xian Wanlong Pharmaceutical Main Business
Table 122. Xian Wanlong Pharmaceutical Latest Developments
Table 123. Morepen Laboratories Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 124. Morepen Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
Table 125. Morepen Laboratories Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Morepen Laboratories Main Business
Table 127. Morepen Laboratories Latest Developments
Table 1. Vonoprazan Fumarate API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vonoprazan Fumarate API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 6. Global Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Table 7. Global Vonoprazan Fumarate API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vonoprazan Fumarate API Revenue Market Share by Type (2018-2023)
Table 9. Global Vonoprazan Fumarate API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 11. Global Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Table 12. Global Vonoprazan Fumarate API Revenue by Application (2018-2023)
Table 13. Global Vonoprazan Fumarate API Revenue Market Share by Application (2018-2023)
Table 14. Global Vonoprazan Fumarate API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Vonoprazan Fumarate API Sales by Company (2018-2023) & (Kg)
Table 16. Global Vonoprazan Fumarate API Sales Market Share by Company (2018-2023)
Table 17. Global Vonoprazan Fumarate API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vonoprazan Fumarate API Revenue Market Share by Company (2018-2023)
Table 19. Global Vonoprazan Fumarate API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Vonoprazan Fumarate API Producing Area Distribution and Sales Area
Table 21. Players Vonoprazan Fumarate API Products Offered
Table 22. Vonoprazan Fumarate API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vonoprazan Fumarate API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Vonoprazan Fumarate API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vonoprazan Fumarate API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vonoprazan Fumarate API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vonoprazan Fumarate API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Vonoprazan Fumarate API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vonoprazan Fumarate API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vonoprazan Fumarate API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vonoprazan Fumarate API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Vonoprazan Fumarate API Sales Market Share by Country (2018-2023)
Table 35. Americas Vonoprazan Fumarate API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vonoprazan Fumarate API Revenue Market Share by Country (2018-2023)
Table 37. Americas Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Vonoprazan Fumarate API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Vonoprazan Fumarate API Sales Market Share by Region (2018-2023)
Table 41. APAC Vonoprazan Fumarate API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vonoprazan Fumarate API Revenue Market Share by Region (2018-2023)
Table 43. APAC Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Vonoprazan Fumarate API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Vonoprazan Fumarate API Sales Market Share by Country (2018-2023)
Table 47. Europe Vonoprazan Fumarate API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vonoprazan Fumarate API Revenue Market Share by Country (2018-2023)
Table 49. Europe Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Vonoprazan Fumarate API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vonoprazan Fumarate API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vonoprazan Fumarate API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vonoprazan Fumarate API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Vonoprazan Fumarate API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Vonoprazan Fumarate API
Table 58. Key Market Challenges & Risks of Vonoprazan Fumarate API
Table 59. Key Industry Trends of Vonoprazan Fumarate API
Table 60. Vonoprazan Fumarate API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vonoprazan Fumarate API Distributors List
Table 63. Vonoprazan Fumarate API Customer List
Table 64. Global Vonoprazan Fumarate API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Vonoprazan Fumarate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vonoprazan Fumarate API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Vonoprazan Fumarate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vonoprazan Fumarate API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Vonoprazan Fumarate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vonoprazan Fumarate API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Vonoprazan Fumarate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vonoprazan Fumarate API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Vonoprazan Fumarate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vonoprazan Fumarate API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Vonoprazan Fumarate API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vonoprazan Fumarate API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Vonoprazan Fumarate API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ami Lifesciences Private Limited Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 79. Ami Lifesciences Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
Table 80. Ami Lifesciences Private Limited Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Ami Lifesciences Private Limited Main Business
Table 82. Ami Lifesciences Private Limited Latest Developments
Table 83. Dr. Reddy's Laboratories Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 84. Dr. Reddy's Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
Table 85. Dr. Reddy's Laboratories Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Dr. Reddy's Laboratories Main Business
Table 87. Dr. Reddy's Laboratories Latest Developments
Table 88. Hetero Drugs Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 89. Hetero Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
Table 90. Hetero Drugs Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Hetero Drugs Main Business
Table 92. Hetero Drugs Latest Developments
Table 93. Metrochem API Private Limited Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 94. Metrochem API Private Limited Vonoprazan Fumarate API Product Portfolios and Specifications
Table 95. Metrochem API Private Limited Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Metrochem API Private Limited Main Business
Table 97. Metrochem API Private Limited Latest Developments
Table 98. Nippon Zhenlei Chemical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 99. Nippon Zhenlei Chemical Vonoprazan Fumarate API Product Portfolios and Specifications
Table 100. Nippon Zhenlei Chemical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Nippon Zhenlei Chemical Main Business
Table 102. Nippon Zhenlei Chemical Latest Developments
Table 103. Virupaksha Organics Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 104. Virupaksha Organics Vonoprazan Fumarate API Product Portfolios and Specifications
Table 105. Virupaksha Organics Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Virupaksha Organics Main Business
Table 107. Virupaksha Organics Latest Developments
Table 108. Zhejiang Hengkang Pharmaceutical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
Table 110. Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Zhejiang Hengkang Pharmaceutical Main Business
Table 112. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 113. Maithri Drugs Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 114. Maithri Drugs Vonoprazan Fumarate API Product Portfolios and Specifications
Table 115. Maithri Drugs Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Maithri Drugs Main Business
Table 117. Maithri Drugs Latest Developments
Table 118. Xian Wanlong Pharmaceutical Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 119. Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Product Portfolios and Specifications
Table 120. Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Xian Wanlong Pharmaceutical Main Business
Table 122. Xian Wanlong Pharmaceutical Latest Developments
Table 123. Morepen Laboratories Basic Information, Vonoprazan Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 124. Morepen Laboratories Vonoprazan Fumarate API Product Portfolios and Specifications
Table 125. Morepen Laboratories Vonoprazan Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Morepen Laboratories Main Business
Table 127. Morepen Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vonoprazan Fumarate API
Figure 2. Vonoprazan Fumarate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vonoprazan Fumarate API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Vonoprazan Fumarate API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vonoprazan Fumarate API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Vonoprazan Fumarate API Sales Market Share by Type in 2022
Figure 12. Global Vonoprazan Fumarate API Revenue Market Share by Type (2018-2023)
Figure 13. Vonoprazan Fumarate API Consumed in Tablets
Figure 14. Global Vonoprazan Fumarate API Market: Tablets (2018-2023) & (Kg)
Figure 15. Vonoprazan Fumarate API Consumed in Others
Figure 16. Global Vonoprazan Fumarate API Market: Others (2018-2023) & (Kg)
Figure 17. Global Vonoprazan Fumarate API Sales Market Share by Application (2022)
Figure 18. Global Vonoprazan Fumarate API Revenue Market Share by Application in 2022
Figure 19. Vonoprazan Fumarate API Sales Market by Company in 2022 (Kg)
Figure 20. Global Vonoprazan Fumarate API Sales Market Share by Company in 2022
Figure 21. Vonoprazan Fumarate API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Vonoprazan Fumarate API Revenue Market Share by Company in 2022
Figure 23. Global Vonoprazan Fumarate API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Vonoprazan Fumarate API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 26. Americas Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 28. APAC Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 30. Europe Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 32. Middle East & Africa Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Vonoprazan Fumarate API Sales Market Share by Country in 2022
Figure 34. Americas Vonoprazan Fumarate API Revenue Market Share by Country in 2022
Figure 35. Americas Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 36. Americas Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 37. United States Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Vonoprazan Fumarate API Sales Market Share by Region in 2022
Figure 42. APAC Vonoprazan Fumarate API Revenue Market Share by Regions in 2022
Figure 43. APAC Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 44. APAC Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 45. China Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Vonoprazan Fumarate API Sales Market Share by Country in 2022
Figure 53. Europe Vonoprazan Fumarate API Revenue Market Share by Country in 2022
Figure 54. Europe Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 55. Europe Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 56. Germany Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Vonoprazan Fumarate API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vonoprazan Fumarate API in 2022
Figure 71. Manufacturing Process Analysis of Vonoprazan Fumarate API
Figure 72. Industry Chain Structure of Vonoprazan Fumarate API
Figure 73. Channels of Distribution
Figure 74. Global Vonoprazan Fumarate API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Vonoprazan Fumarate API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Vonoprazan Fumarate API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Vonoprazan Fumarate API
Figure 2. Vonoprazan Fumarate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vonoprazan Fumarate API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Vonoprazan Fumarate API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vonoprazan Fumarate API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Vonoprazan Fumarate API Sales Market Share by Type in 2022
Figure 12. Global Vonoprazan Fumarate API Revenue Market Share by Type (2018-2023)
Figure 13. Vonoprazan Fumarate API Consumed in Tablets
Figure 14. Global Vonoprazan Fumarate API Market: Tablets (2018-2023) & (Kg)
Figure 15. Vonoprazan Fumarate API Consumed in Others
Figure 16. Global Vonoprazan Fumarate API Market: Others (2018-2023) & (Kg)
Figure 17. Global Vonoprazan Fumarate API Sales Market Share by Application (2022)
Figure 18. Global Vonoprazan Fumarate API Revenue Market Share by Application in 2022
Figure 19. Vonoprazan Fumarate API Sales Market by Company in 2022 (Kg)
Figure 20. Global Vonoprazan Fumarate API Sales Market Share by Company in 2022
Figure 21. Vonoprazan Fumarate API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Vonoprazan Fumarate API Revenue Market Share by Company in 2022
Figure 23. Global Vonoprazan Fumarate API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Vonoprazan Fumarate API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 26. Americas Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 28. APAC Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 30. Europe Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Vonoprazan Fumarate API Sales 2018-2023 (Kg)
Figure 32. Middle East & Africa Vonoprazan Fumarate API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Vonoprazan Fumarate API Sales Market Share by Country in 2022
Figure 34. Americas Vonoprazan Fumarate API Revenue Market Share by Country in 2022
Figure 35. Americas Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 36. Americas Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 37. United States Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Vonoprazan Fumarate API Sales Market Share by Region in 2022
Figure 42. APAC Vonoprazan Fumarate API Revenue Market Share by Regions in 2022
Figure 43. APAC Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 44. APAC Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 45. China Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Vonoprazan Fumarate API Sales Market Share by Country in 2022
Figure 53. Europe Vonoprazan Fumarate API Revenue Market Share by Country in 2022
Figure 54. Europe Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 55. Europe Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 56. Germany Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Vonoprazan Fumarate API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Vonoprazan Fumarate API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Vonoprazan Fumarate API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vonoprazan Fumarate API in 2022
Figure 71. Manufacturing Process Analysis of Vonoprazan Fumarate API
Figure 72. Industry Chain Structure of Vonoprazan Fumarate API
Figure 73. Channels of Distribution
Figure 74. Global Vonoprazan Fumarate API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Vonoprazan Fumarate API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Vonoprazan Fumarate API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Vonoprazan Fumarate API Revenue Market Share Forecast by Application (2024-2029)
